Cargando…
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
The avian paramyxovirus, Newcastle disease virus (NDV), is a promising oncolytic agent that has been shown to be safe and effective in a variety of pre-clinical cancer models and human clinical trials. NDV preferentially replicates in tumor cells due to signaling defects in apoptotic and antiviral p...
Autores principales: | McAusland, Thomas M., van Vloten, Jacob P., Santry, Lisa A., Guilleman, Matthew M., Rghei, Amira D., Ferreira, Edgar M., Ingrao, Joelle C., Arulanandam, Rozanne, Major, Pierre P., Susta, Leonardo, Karimi, Khalil, Diallo, Jean-Simon, Bridle, Byram W., Wootton, Sarah K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868934/ https://www.ncbi.nlm.nih.gov/pubmed/33614913 http://dx.doi.org/10.1016/j.omto.2021.01.009 |
Ejemplares similares
-
Production and Purification of High-Titer Newcastle Disease Virus for Use in Preclinical Mouse Models of Cancer
por: Santry, Lisa A., et al.
Publicado: (2017) -
Production and purification of high-titer OrfV for preclinical studies in vaccinology and cancer therapy
por: van Vloten, Jacob P., et al.
Publicado: (2021) -
AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020) -
Quantifying Antigen-Specific T Cell Responses When Using Antigen-Agnostic Immunotherapies
por: van Vloten, Jacob P., et al.
Publicado: (2019) -
AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma
por: Stegelmeier, Ashley A., et al.
Publicado: (2022)